2025 Q1 Form 10-Q Financial Statement

#000147793225000225 Filed on January 14, 2025

View on sec.gov

Income Statement

Concept 2025 Q1 2024 Q3 2024 Q2
Revenue $20.06K
YoY Change 1019.48%
Cost Of Revenue $0.00
YoY Change
Gross Profit $20.06K
YoY Change 1019.48%
Gross Profit Margin 100.0%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $98.35K
YoY Change 139.2%
Operating Profit -$78.28K
YoY Change 99.08%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$78.45K
YoY Change 99.51%
Net Earnings / Revenue -391.07%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 2.096B shares 2.096B shares 2.096B shares
Diluted Shares Outstanding 2.096B shares

Balance Sheet

Concept 2025 Q1 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $307.3K $25.94K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $4.405M $3.962M
Prepaid Expenses
Receivables $0.00 $0.00
Other Receivables
Total Short-Term Assets $4.712M $3.988M
YoY Change 4253.9% 3973.03%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $4.712M $3.988M
Total Long-Term Assets $0.00 $0.00
Total Assets $4.712M $3.988M
YoY Change 4222.67% 3939.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.303M $3.692M
YoY Change 184.41% 115.8%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $5.228M $5.036M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.303M $3.692M
Total Long-Term Liabilities $5.228M $5.036M
Total Liabilities $9.531M $8.728M
YoY Change 528.81%
SHAREHOLDERS EQUITY
Retained Earnings -$1.378M -$1.300M
YoY Change -51.45% -53.6%
Common Stock $209.6K $209.6K
YoY Change -0.01% -0.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $4.712M $3.988M
YoY Change 4222.67% 3939.41%

Cashflow Statement

Concept 2025 Q1 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$78.45K
YoY Change 99.51%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $89.26K
YoY Change -146.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $192.1K
YoY Change -456.69%
NET CHANGE
Cash From Operating Activities $89.26K
Cash From Investing Activities $0.00
Cash From Financing Activities $192.1K
Net Change In Cash $281.3K
YoY Change 25828.48%
FREE CASH FLOW
Cash From Operating Activities $89.26K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001683252
CY2024Q3 dei Amendment Flag
AmendmentFlag
false
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2025
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095671162 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095671162 shares
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2095671162 shares
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
CY2024Q3 dei Entity File Number
EntityFileNumber
000-55688
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
Token Communities Ltd.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3709511
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
850 Tidewater Shore Loop
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 402
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Bradenton
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34208
CY2024Q3 dei City Area Code
CityAreaCode
631
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
397-1111
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2025Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2095872947 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
307263 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25939 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
4404918 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
3961964 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
4712181 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
3987903 usd
CY2024Q3 us-gaap Assets
Assets
4712181 usd
CY2024Q2 us-gaap Assets
Assets
3987903 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
133573 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
126573 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
352156 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
352156 usd
CY2024Q3 tkcm Unearned Revenue Current
UnearnedRevenueCurrent
552 usd
CY2024Q2 tkcm Unearned Revenue Current
UnearnedRevenueCurrent
552 usd
CY2024Q3 tkcm Due To Related Party Current
DueToRelatedPartyCurrent
3816662 usd
CY2024Q2 tkcm Due To Related Party Current
DueToRelatedPartyCurrent
3213162 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4302943 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3692443 usd
CY2024Q3 us-gaap Construction Loan Noncurrent
ConstructionLoanNoncurrent
228022 usd
CY2024Q2 us-gaap Construction Loan Noncurrent
ConstructionLoanNoncurrent
35960 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
5000000 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
5000000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5228022 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5035960 usd
CY2024Q3 us-gaap Liabilities
Liabilities
9530965 usd
CY2024Q2 us-gaap Liabilities
Liabilities
8728403 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095671162 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
209567 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
209567 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-3640360 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
-3640360 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1378430 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1299977 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
-9561 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
-9730 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4818784 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4740500 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4712181 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3987903 usd
CY2024Q3 tkcm Gross Margin On Home Sales
GrossMarginOnHomeSales
0 usd
CY2023Q3 tkcm Gross Margin On Home Sales
GrossMarginOnHomeSales
0 usd
CY2024Q3 tkcm Gross Margin On Lot Sales And Other
GrossMarginOnLotSalesAndOther
20061 usd
CY2024Q3 tkcm Rent Expenses
RentExpenses
0 usd
CY2023Q3 tkcm Rent Expenses
RentExpenses
0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-78284 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-39323 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
169 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-78453 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-37389 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2095671162 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2095671162 shares
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1386948 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3772 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-39323 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1422499 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4740500 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-78284 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-4818784 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
-78284 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-39323 usd
CY2024Q3 tkcm Other Equity Adjustments
OtherEquityAdjustments
0 usd
CY2023Q3 tkcm Other Equity Adjustments
OtherEquityAdjustments
0 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
442954 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
0 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4735 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
603500 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
31913 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
89262 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2675 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
CY2024Q3 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
192062 usd
CY2023Q3 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0 usd
CY2024Q3 tkcm Repayments Of Acquisition Of Asc Global Inc
RepaymentsOfAcquisitionOfAscGlobalInc
0 usd
CY2023Q3 tkcm Repayments Of Acquisition Of Asc Global Inc
RepaymentsOfAcquisitionOfAscGlobalInc
0 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
192062 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3772 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
281324 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1097 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25939 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1130 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307263 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2227 usd
CY2018Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
19266000 shares
CY2018Q1 tkcm Equity Method Investments Ownership Percentage
EquityMethodInvestmentsOwnershipPercentage
1 pure
CY2018Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
172800000 shares
CY2024Q3 tkcm Number Of Shares Outstanding Prior To Merger
NumberOfSharesOutstandingPriorToMerger
116466000 shares
CY2024Q3 tkcm Surrender Stockholder Shares
SurrenderStockholderShares
19266000 shares
CY2024Q3 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
57107 usd
CY2020Q3 tkcm Stock Cancelled During Period Shares Acquisitions
StockCancelledDuringPeriodSharesAcquisitions
174540600 shares
CY2023Q1 tkcm Promissory Notes Issued To Stockholder
PromissoryNotesIssuedToStockholder
225000 usd
CY2024Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
4818784 usd
CY2024Q3 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
0.0000 pure
CY2023Q3 us-gaap Derivative Forward Exchange Rate1
DerivativeForwardExchangeRate1
1.2199 pure
CY2024Q3 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
0.0000 pure
CY2023Q3 us-gaap Derivative Average Forward Exchange Rate1
DerivativeAverageForwardExchangeRate1
0.1374 pure
CY2024Q3 tkcm Gains And Losses On Extinguishment Of Debt
GainsAndLossesOnExtinguishmentOfDebt
730820 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of CFS in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the CFS and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2024Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the three months ended September 30, 2023, the Company identified an immaterial error related to the exclusion of cash balances that impacted the Company’s previously issued June 30, 2023, consolidated financial statements. Management evaluated the effect of the error on the June 30, 2023, financial statements and concluded the error was not material. As a result, in the three months ended September 30, 2023, the Company recorded an out of period adjustment to increase cash, increase related party debt and increase accumulated deficit.</p>
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2095671162 shares
CY2024Q3 us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each outstanding share of common stock entitles the holder to one vote per share on all matters submitted to a stockholder vote. All shares of common stock are non-assessable and non-cumulative, with no pre-emptive ri
CY2024Q2 tkcm Promissory Notes Issued To Stockholder
PromissoryNotesIssuedToStockholder
5000000 usd
CY2024Q3 tkcm Non Review Textblock
NonReviewTextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 9 – NON REVIEW</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024 (the “Form 10-Q”), was prepared without the consent of its independent accountant, Beckles &amp; Co. Inc. (“Beckles &amp; Co.”) in respect of unaudited interim financial information as of and for the three period ended September 30, 2024 set forth herein, as required by Statement on Auditing Standards No. 100, Interim Financial Statements (the “SAS 100 Review”). Due to the fact that Beckles &amp; Co.s’ SAS 100 Review has not yet been done, the consolidated balance sheets, condensed financial statements as of and for the three month period ended September 30, 2024 included in the Form 10-Q should not be relied upon. The Company intends to file an amended Form 10-Q upon completion of Beckles &amp; Co. s’ SAS 100 Review.</p>
CY2024Q3 tkcm Revenue From Home Sales
RevenueFromHomeSales
0 usd
CY2023Q3 tkcm Revenue From Home Sales
RevenueFromHomeSales
0 usd
CY2024Q3 tkcm Revenue From Lot Sales And Other
RevenueFromLotSalesAndOther
20061 usd
CY2023Q3 tkcm Revenue From Lot Sales And Other
RevenueFromLotSalesAndOther
1792 usd
CY2024Q3 us-gaap Revenues
Revenues
20061 usd
CY2023Q3 tkcm Gross Margin On Lot Sales And Other
GrossMarginOnLotSalesAndOther
1792 usd
CY2024Q3 tkcm Cost Of Home Sales
CostOfHomeSales
0 usd
CY2023Q3 tkcm Cost Of Home Sales
CostOfHomeSales
0 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q3 us-gaap Revenues
Revenues
1792 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
20061 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1792 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
0 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11578 usd
CY2024Q3 us-gaap Legal Fees
LegalFees
30500 usd
CY2023Q3 us-gaap Legal Fees
LegalFees
18594 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
67845 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10943 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
98345 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
41115 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-78284 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-39323 usd
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1934 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3772 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78453 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33617 usd
CY2024Q3 tkcm Related Party Transaction Due To Related Parties
RelatedPartyTransactionDueToRelatedParties
3816662 usd
CY2024Q2 tkcm Related Party Transaction Due To Related Parties
RelatedPartyTransactionDueToRelatedParties
3213162 usd
CY2024Q3 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.04 pure
CY2024Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2027-05-10
CY2024Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
78333 usd

Files In Submission

Name View Source Status
0001477932-25-000225-index-headers.html Edgar Link pending
0001477932-25-000225-index.html Edgar Link pending
0001477932-25-000225.txt Edgar Link pending
0001477932-25-000225-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tkcm-20240930.xsd Edgar Link pending
tkcm_10q.htm Edgar Link pending
tkcm_ex311.htm Edgar Link pending
tkcm_ex312.htm Edgar Link pending
tkcm_ex321.htm Edgar Link pending
tkcm-20240930_cal.xml Edgar Link unprocessable
tkcm-20240930_def.xml Edgar Link unprocessable
tkcm-20240930_lab.xml Edgar Link unprocessable
tkcm-20240930_pre.xml Edgar Link unprocessable
tkcm_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable